TAH3311
Anticoagulation (Apixaban)
Phase 3Active
Key Facts
About TAHO Pharmaceuticals
TAHO Pharma delivers novel transdermal and oral‑film drug formats to address unmet patient needs across cardiovascular, neurology, and oncology markets.
View full company profile